官方网：促进核酸检测结论全国各地双边协定在本省做出来的核酸检测到省外还有效么?合理，7日里的核酸检测证实全国通用。根据我国卫健委官网公布《关于做好精准健康管理推荐人员有序流动的通知》中明确提出，有中高风险级别地域旅居生活史的工作人员，跨区域流动性时须持有到达目的地前7日内核酸检测阴性证明或可以提供包括核酸检测阴性信息的健康通行码“绿码”。假如核酸检测超出7天，还要再度检测，但一般7天之后没有到过瘟疫区，没有接触过疑似患者，不用再度做核酸检测，平常出门的时候尽量佩戴口罩，少到人口密集的地方，讲究卫生，房间内应该及时的自然通风。

官方网：促进核酸检测结论全国各地双边协定

在本省做出来的核酸检测到省外还有效么?

合理，7日里的核酸检测证实全国通用。

根据我国卫健委官网公布《关于做好精准健康管理推荐人员有序流动的通知》中明确提出，有中高风险级别地域旅居生活史的工作人员，跨区域流动性时须持有到达目的地前7日内核酸检测阴性证明或可以提供包括核酸检测阴性信息的健康通行码“绿码”。假如核酸检测超出7天，还要再度检测，但一般7天之后没有到过瘟疫区，没有接触过疑似患者，不用再度做核酸检测，平常出门的时候尽量佩戴口罩，少到人口密集的地方，讲究卫生，房间内应该及时的自然通风。

核酸检测是搜索患者的呼吸系统样本、血夜或排泄物中是否存在外来入侵的病毒的核酸，来确定是否被新型冠状病毒感柒，因而一旦检测为核苷酸“呈阳性”，就可以证实病人体内有病毒感染存有，但这种检测可出现假阳或假阴性的结果，而且即使时下检测出检测者是阴性的未感染病毒者，后面因其他情况感染了病毒，也会出现呈阳性，因而曾进行了核酸检测并不是代表万无一失，到另外一个大城市后也还是有必要再做出来的。

做了核酸检测后呈阴性，只有代表本次核酸检测没问题，但是否需要防护，与是否有新冠状病毒确诊患者异常接触史，是否在高风险地域及其是否有流行病学史、国外旅游居住史等这些流行病学特征有关，如果被检测者来自于低风险区，并没有新冠肺炎的临床流行病学接触史，当检测结论合格时一般就不需要再开展防护。

假如来自于高风险区，或者是有新冠肺炎的密切接触史，即便是检测结论合格，仍然需要开展防护。另外对于高风险群体，一次核酸检测阴性并不能完全清除。由于核苷酸采集标本的关系，有可能会出现假阴性，因此建议在24小时后还需要再度复诊核苷酸，在这段时间也应当遵循要求进行防护预防措施。

Official: promote the national mutual recognition of nucleic acid test results. Is the nucleic acid test done in this province still effective in other provinces? Valid. The nucleic acid test within 7 days proves that it is universal in China. According to the notice on orderly flow of recommended personnel for accurate health management released on the official website of the National Health Commission, it is clearly pointed out that personnel with a history of living in medium and high-risk areas must hold a negative nucleic acid test certificate or be able to show a health pass code "green code" containing negative nucleic acid test information within 7 days before arriving at the destination. If the nucleic acid test lasts for more than 7 days, it needs to be tested again. However, generally, it is not necessary to do the nucleic acid test again if you have not been to the epidemic area after 7 days and have not contacted the suspected patients. You should wear a mask when you go out at ordinary times. As few as densely populated places, you should wash your hands frequently, and the room should be ventilated in time. Nucleic acid detection is to find out whether there is foreign virus nucleic acid in the respiratory tract samples, blood or feces of patients to determine whether they are infected by novel coronavirus. Therefore, once the nucleic acid is detected as "positive", it can prove that there is a virus in the patient, but this detection can show false positive or false negative results. Moreover, even if the non infected person who is detected as negative at the moment will also be positive if he is infected with the virus due to other conditions. Therefore, having done nucleic acid detection does not mean that it is safe. It is still necessary to do it again after arriving in another city. A negative result after the nucleic acid test can only mean that there is no problem in the current nucleic acid test, but whether isolation is required is related to the epidemiological characteristics such as whether there is a suspected contact history of patients diagnosed with novel coronavirus, whether they are in high-risk areas, whether they have an epidemiological history, foreign travel and residence history, etc. if the tested person comes from a low-risk area and has no epidemiological contact history of COVID-19, isolation is generally not required when the test results are qualified. If it comes from a high-risk area or has a history of close contact with COVID-19, even if the test results are qualified, it still needs to be isolated. In addition, for high-risk people, a negative nucleic acid test cannot be completely ruled out. Due to the collection of nucleic acid samples, false negatives may occur. Therefore, it is recommended that the nucleic acid should be rechecked after 24 hours. During this period, isolation and preventive measures should also be taken as required.

核酸检测再降价！单人单检不高于每人份16元

由来：

人民网北京5月25日电 （新闻记者乔业琼）为贯彻落实新冠病毒肺部感染新冠肺炎防控规定，相互配合搞好规模性筛选和常态检测工作，减少人民群众压力和社会成本，前不久，我国医疗保障局公司办公室、国务院令解决新型冠状病毒肺炎疫情联防联控机制医疗救治组联合发文《有关进一步降低新冠病毒核酸检测和抗原检测价格的通知》（下称《通知》）。

《通知》规定，进一步下降公立医疗机构新冠病毒核酸检测的政府指导价，各省份要把1人单检降到不高于每个人份16元，多的人混检统一降到不高于每个人份5元。推行检验价格和实验试剂价格分离计费收费的省份，按照不高于以上水准设定封顶规范。

公立医疗机构开展的新冠病毒抗原检测服务项目，依照“价格新项目 检测试剂”的方式收费。在其中，“新冠抗原检验”健康服务价格项目的政府指导价降到不高于每个人份2元；新冠抗原检测试剂（含取样器材）按照实际购置价格零差率销售；“价格新项目 检测试剂”收费总额的封顶规范降到不高于每个人份6元。

针对政府组织的大规模筛选、常态检验，要综合考虑到规模效益和基层党建、青年志愿者对成本的分摊效用，新冠病毒核苷酸多的人混检依照不高于每个人份3.5块的标准计费，检测中心仅给予样版装运及测试服务的，需进一步降低收费规范。

各省份医保部门参照目前全国已有的挂网采购价格，在6月10日以前，根据组织实施采购、竟价挂标、参加跨地区同盟购置、地区价格较为等多种形式，使公立医疗机构能将新冠肺炎核酸检测需要增加实验试剂、获取实验试剂、取样器材等物料消耗成本费降到1人单检价格的40%之内。

据了解，这也是国家医保局运行第五轮全国各地联动，具体指导全国各地进一步降低公立三甲医院新冠病毒核酸检测的价格和费用。

文中来源于，仅代表原作者看法。全国党媒信息内容管理平台给予发布信息散播服务项目。